Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0019079 (
hemoptysis
)
6,129
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Sildenafil
is widely used in the treatment of male erectile disorder and is generally well-tolerated. Its adverse effects are reported to be mild and include flushing, headache, dyspepsia and visual disturbances. We document a case of recurrent
haemoptysis
observed soon after self administration of sildenafil in a 38-year-old male with no other causative factors. The episodes of
haemoptysis
stopped following stoppage of sildenafil.
...
PMID:Recurrent haemoptysis following sildenafil administration. 1944 50
Sildenafil
, usually a well-tolerated drug traditionally used for erectile dysfunction (ED), was recently approved for pulmonary arterial hypertension. In the literature, there are few cases of
hemoptysis
following sildenafil use for ED; however, to our knowledge, we are reporting the first case of
hemoptysis
following sildenafil use for pulmonary hypertension. We are documenting a case of a 90-year-old male patient who was admitted to the intensive care unit with
hemoptysis
and respiratory failure two weeks after he was started on sildenafil.
...
PMID:Hemoptysis and respiratory failure following sildenafil use for pulmonary hypertension. 2354 89
Sildenafil
is one of the most commonly used drugs for sexual dysfunction or to increase libido, and it regulates endothelial nitric oxide synthase enzyme via selective phosphodiesterase-V inhibition.
Sildenafil
can be easily obtained without a medical indication or prescription yet it is not considered as a completely safe medication.
Hemoptysis
and hemorrhagic stroke are some important adverse effects of sildenafil. The case of the current report was a 67-year-old diabetic patient with simultaneous anterior and posterior segment hemorrhage after the use of 100 mg sildenafil citrate. Anterior chamber clearance and pars plana vitrectomy were performed for the patient because the hyphema and vitreous hemorrhage did not resolve during the follow-up period. There are very limited data available in the literature suggesting an increase in the risk of hyphema or vitreous hemorrhage due to the use of sildenafil. This is the first report that reveals the bleeding effect of sildenafil use in a patient with type 2 diabetes.
...
PMID:Intraocular Hemorrhage due to use of Sildenafil in a Patient with Diabetes. 3038 1